Sonova Holding AGXSWX:SOON -3.09%92 Return-on-Tangible-Asset is 17.02% as of Mar. 2026, which is 26% below its 10-year median of 23.04. GuruFocus rates XSWX:SOON with a GF Score™ of 92/100 and a GF Value™ of CHF250.17 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Sonova Holding AG ranks better than 91.69% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Sonova Holding AG's annualizedNet Income for the quarter that ended in Mar. 2026 was CHF484 Mil. Sonova Holding AG's average total tangible assets for the quarter that ended in Mar. 2026 was CHF2,845 Mil. Therefore, Sonova Holding AG's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 17.02%.
The historical rank and industry rank for Sonova Holding AG's Return-on-Tangible-Asset or its related term are showing as below:
XSWX:SOON'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 14.48 Med: 23.04 Max: 25.22
Current: 14.97
During the past 13 years, Sonova Holding AG's highest Return-on-Tangible-Asset was 25.22%. The lowest was 14.48%. And the median was 23.04%.
XSWX:SOON's Return-on-Tangible-Asset is ranked better than 91.69% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.665
vs XSWX:SOON: 14.97
Sonova Holding AG (XSWX:SOON) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Sonova Holding AG Return-on-Tangible-Asset Related Terms
Sonova Holding AG Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Sonova Holding AG's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SOON vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Sonova Holding AG's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sonova Holding AG Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sonova Holding AG's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Sonova Holding AG's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 17.02% mean?
Sonova Holding AG (XSWX:SOON) has a Return-on-Tangible-Asset of 17.02% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Sonova Holding AG and its competitors. This is 26% below median its historical median of 23.04. Over the past decade, Sonova Holding AG's Return-on-Tangible-Asset has ranged from 14.48 to 25.22. According to the industry distribution chart, Sonova Holding AG ranks #71 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 8.3%.
Is Sonova Holding AG's Return-on-Tangible-Asset too high?
Sonova Holding AG's current Return-on-Tangible-Asset of 17.02% is 26% below median its 10-year median of 23.04. Over the past 10 years, this metric has ranged from a low of 14.48 to a high of 25.22. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.67. Sonova Holding AG's value of 17.02% is 2459.4% above this industry median. Based on the distribution chart, Sonova Holding AG ranks #71 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sonova Holding AG has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonova Holding AG's Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sonova Holding AG ranks #71 out of 854 companies for Return-on-Tangible-Asset. This places Sonova Holding AG in the top 8% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.67. Sonova Holding AG's value of 17.02% is 2459.4% above this benchmark. Historically, Sonova Holding AG's own Return-on-Tangible-Asset has ranged from 14.48 to 25.22 over the past decade. While the company's 10-year median is 23.04 vs. the industry median of 0.67, Sonova Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.67, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sonova Holding AG's current Return-on-Tangible-Asset of 17.02% is 2459.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Sonova Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sonova Holding AG's current Return-on-Tangible-Asset is 17.02%, which is 26% below median its own 10-year median of 23.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonova Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Sonova Holding AG (XSWX:SOON) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF250.17, compared to a current price of CHF201.00 — trading 19.7% below its estimated fair value. The current Return-on-Tangible-Asset is 17.02%, which is 26% below median its 10-year median of 23.04 and 2459.4% above the Medical Devices & Instruments industry median of 0.67. Sonova Holding AG's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Sonova Holding AG (XSWX:SOON), the current Return-on-Tangible-Asset is 17.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sonova Holding AG (XSWX:SOON) Overvalued in 2026?
Based on GuruFocus' analysis, Sonova Holding AG stock appears to be undervalued.
The current stock price of CHF201.00 is trading 19.7% below its estimated GF Value™ of CHF250.17.
GuruFocus considers Sonova Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:SOON:
Return-on-Tangible-Asset: 17.02% (26% below median its 10-year median of 23.04)
GF Value™: CHF250.17 vs. price of CHF201.00 (19.7% below fair value)
Industry Position: 2459.4% above the Medical Devices & Instruments median (#71 of 854)
No single metric tells the full story. See the XSWX:SOON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sonova is one of the world's largest manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants and audio technologies.
92GF Score
Get the complete analysis for XSWX:SOON
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SOON has been successfully added to your 
